Blog Archives

Epigenetic Programs and Cancer Progression

Translating Cancer Biology into Novel Therapies

How Machine Intelligence Could Accelerate Holographic Medical Imaging

Agents and Homunculi: Does it Take a Village to Make a Conscious Organism?

Realizing SomaLogic’s Dream: Plans to Deploy Large Scale Proteomics to Guide Best Health

DE-CRUIT® Treating Trauma Through Shakespeare and Science

High-Reliability, Person-Centered Health Care: It Can’t Happen without the National Library of Medicine

Welcome to the 9th Annual GoldLab Symposium

Larry Gold, Ph.D. is the Founder and Chairman of the board, and past CEO of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases. Before forming NeXagen, he also co-founded and served as Co-Director of research at Synergen, Inc., a biotechnology company later acquired by Amgen, Inc.

Rethinking U.S.­ Foreign Policy

Doped and Duped: Deviance, Coercion, and Irony in both Sport and Medicine